Lipoprotein processing is essential for resistance of Mycobacterium tuberculosis to malachite green

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 9, 2009, Pages 3799-3802

  Banaei, Niaz ^a,d   Kincaid, Eleanor Z ^a   Lin, S Y Grace ^b   Desmond, Edward ^b   Jacobs Jr , William R ^c   Ernst, Joel D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DODECYL SULFATE SODIUM; LIPOPROTEIN; LIPOPROTEIN SIGNAL PEPTIDASE A; MALACHITE GREEN; PEPTIDASE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL MEMBRANE PERMEABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG STRUCTURE; HYPERSENSITIVITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; ROSANILINE DYES;

EID: 70349097651     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00647-09     Document Type: Article

References (22)

1. Alderman, D. J. 1985. Malachite green: a review. J. Fish Dis. 8:289-298.
2. Banaiee, N., E. Z. Kincaid, U. Buchwald, W. R. Jacobs, Jr., and J. D. Ernst. 2006. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J. Immunol. 176:3019-3027. (Pubitemid 43306963)
3. Blumenthal, A., T. Kobayashi, L. M. Pierini, N. Banaei, J. D. Ernst, K. Miyake, and S. Ehrt. 2009. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe 5:35-46.
4. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:29-63.
5. Camacho, L. R., P. Constant, C. Raynaud, M. A. Laneelle, J. A. Triccas, B. Gicquel, M. Daffe, and C. Guilhot. 2001. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276:19845-19854.
6. Cox, J. S., B. Chen, M. McNeil, and W. R. Jacobs, Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79-83.
7. Darwin, K. H., S. Ehrt, J. C. Gutierrez-Ramos, N. Weich, and C. F. Nathan. 2003. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302:1963-1966. (Pubitemid 37523503)
8. Jarlier, V., and H. Nikaido. 1994. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123:11-18.
9. Jones, J. J., and J. O. Falkinham III. 2003. Decolorization of malachite green and crystal violet by waterborne pathogenic mycobacteria. Antimicrob. Agents Chemother. 47:2323-2326.
10. Lamichhane, G., M. Zignol, N. J. Blades, D. E. Geiman, A. Dougherty, J. Grosset, K. W. Broman, and W. R. Bishai. 2003. A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 100:7213-7218.
11. Murray, P. R., and E. J. Baron (ed.). 2007. Manual of clinical microbiology. ASM Press, Washington, DC.
12. Raviglione, M. C. 2003. The TB epidemic from 1992 to 2002. Tuberculosis (Edinburgh) 83:4-14.
13. Safranek, T. J., W. R. Jarvis, L. A. Carson, L. B. Cusick, L. A. Bland, J. M. Swenson, and V. A. Silcox. 1987. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N. Engl. J. Med. 317:197-201.
14. Saji, M., S. Taguchi, K. Uchiyama, E. Osono, N. Hayama, and H. Ohkuni. 1995. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J. Hosp. Infect. 31:225-228.
15. Sander, P., M. Rezwan, B. Walker, S. K. Rampini, R. M. Kroppenstedt, S. Ehlers, C. Keller, J. R. Keeble, M. Hagemeier, M. J. Colston, B. Springer, and E. C. Bottger. 2004. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 52:1543-1552.
16. Sassetti, C. M., D. H. Boyd, and E. J. Rubin. 2003. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48:77-84.
17. Sulzenbacher, G., S. Canaan, Y. Bordat, O. Neyrolles, G. Stadthagen, V. Roig-Zamboni, J. Rauzier, D. Maurin, F. Laval, M. Daffe, C. Cambillau, B. Gicquel, Y. Bourne, and M. Jackson. 2006. LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J. 25:1436-1444.
18. Sutcliffe, I. C., and D. J. Harrington. 2004. Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components. FEMS Microbiol. Rev. 28:645-659.
19. Sutcliffe, I. C., and R. R. B. Russell. 1995. Lipoproteins of gram-positive bacteria. J. Bacteriol. 177:1123-1128.
20. Tarnok, I., and P. Czanik. 1959. Malachite green reducing enzyme in mycobacteria. Nature 183:549-550.
21. Tarshis, M. S., M. V. Parker, and W. B. Dunham. 1955. Blood media for cultivation of Mycobacterium tuberculosis. X. Results with malachite green, penicillin and sodium tellurite and comparison of the blood agar-MGP, blood agar-PST and Lowenstein-Jensen media under routine diagnostic conditions. Acta Tuberc. Scand. 31:92-105.
22. Tokunaga, M., H. Tokunaga, and H. C. Wu. 1982. Post-translational modification and processing of Escherichia coli prolipoprotein in vitro. Proc. Natl. Acad. Sci. USA 79:2255-2259.